Disruption of chromatin organisation causes MEF2C gene overexpression in intellectual disability: a case report
Abstract Background Balanced structural variants are mostly described in disease with gene disruption or subtle rearrangement at breakpoints. Case presentation Here we report a patient with mild intellectual deficiency who carries a de novo balanced translocation t(3;5). Breakpoints were fully explo...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-08-01
|
Series: | BMC Medical Genomics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12920-019-0558-8 |
id |
doaj-af431e66ab844436af04e46b042eb9d4 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Kevin Yauy Anouck Schneider Bee Ling Ng Jean-Baptiste Gaillard Satish Sati Christine Coubes Constance Wells Magali Tournaire Thomas Guignard Pauline Bouret David Geneviève Jacques Puechberty Franck Pellestor Vincent Gatinois |
spellingShingle |
Kevin Yauy Anouck Schneider Bee Ling Ng Jean-Baptiste Gaillard Satish Sati Christine Coubes Constance Wells Magali Tournaire Thomas Guignard Pauline Bouret David Geneviève Jacques Puechberty Franck Pellestor Vincent Gatinois Disruption of chromatin organisation causes MEF2C gene overexpression in intellectual disability: a case report BMC Medical Genomics Intellectual disability (ID) Topologically associated domains (TAD) MEF2C |
author_facet |
Kevin Yauy Anouck Schneider Bee Ling Ng Jean-Baptiste Gaillard Satish Sati Christine Coubes Constance Wells Magali Tournaire Thomas Guignard Pauline Bouret David Geneviève Jacques Puechberty Franck Pellestor Vincent Gatinois |
author_sort |
Kevin Yauy |
title |
Disruption of chromatin organisation causes MEF2C gene overexpression in intellectual disability: a case report |
title_short |
Disruption of chromatin organisation causes MEF2C gene overexpression in intellectual disability: a case report |
title_full |
Disruption of chromatin organisation causes MEF2C gene overexpression in intellectual disability: a case report |
title_fullStr |
Disruption of chromatin organisation causes MEF2C gene overexpression in intellectual disability: a case report |
title_full_unstemmed |
Disruption of chromatin organisation causes MEF2C gene overexpression in intellectual disability: a case report |
title_sort |
disruption of chromatin organisation causes mef2c gene overexpression in intellectual disability: a case report |
publisher |
BMC |
series |
BMC Medical Genomics |
issn |
1755-8794 |
publishDate |
2019-08-01 |
description |
Abstract Background Balanced structural variants are mostly described in disease with gene disruption or subtle rearrangement at breakpoints. Case presentation Here we report a patient with mild intellectual deficiency who carries a de novo balanced translocation t(3;5). Breakpoints were fully explored by microarray, Array Painting and Sanger sequencing. No gene disruption was found but the chromosome 5 breakpoint was localized 228-kb upstream of the MEF2C gene. The predicted Topologically Associated Domains analysis shows that it contains only the MEF2C gene and a long non-coding RNA LINC01226. RNA studies looking for MEF2C gene expression revealed an overexpression of MEF2C in the lymphoblastoid cell line of the patient. Conclusions Pathogenicity of MEF2C overexpression is still unclear as only four patients with mild intellectual deficiency carrying 5q14.3 microduplications containing MEF2C are described in the literature. The microduplications in these individuals also contain other genes expressed in the brain. The patient presented the same phenotype as 5q14.3 microduplication patients. We report the first case of a balanced translocation leading to an overexpression of MEF2C similar to a functional duplication. |
topic |
Intellectual disability (ID) Topologically associated domains (TAD) MEF2C |
url |
http://link.springer.com/article/10.1186/s12920-019-0558-8 |
work_keys_str_mv |
AT kevinyauy disruptionofchromatinorganisationcausesmef2cgeneoverexpressioninintellectualdisabilityacasereport AT anouckschneider disruptionofchromatinorganisationcausesmef2cgeneoverexpressioninintellectualdisabilityacasereport AT beelingng disruptionofchromatinorganisationcausesmef2cgeneoverexpressioninintellectualdisabilityacasereport AT jeanbaptistegaillard disruptionofchromatinorganisationcausesmef2cgeneoverexpressioninintellectualdisabilityacasereport AT satishsati disruptionofchromatinorganisationcausesmef2cgeneoverexpressioninintellectualdisabilityacasereport AT christinecoubes disruptionofchromatinorganisationcausesmef2cgeneoverexpressioninintellectualdisabilityacasereport AT constancewells disruptionofchromatinorganisationcausesmef2cgeneoverexpressioninintellectualdisabilityacasereport AT magalitournaire disruptionofchromatinorganisationcausesmef2cgeneoverexpressioninintellectualdisabilityacasereport AT thomasguignard disruptionofchromatinorganisationcausesmef2cgeneoverexpressioninintellectualdisabilityacasereport AT paulinebouret disruptionofchromatinorganisationcausesmef2cgeneoverexpressioninintellectualdisabilityacasereport AT davidgenevieve disruptionofchromatinorganisationcausesmef2cgeneoverexpressioninintellectualdisabilityacasereport AT jacquespuechberty disruptionofchromatinorganisationcausesmef2cgeneoverexpressioninintellectualdisabilityacasereport AT franckpellestor disruptionofchromatinorganisationcausesmef2cgeneoverexpressioninintellectualdisabilityacasereport AT vincentgatinois disruptionofchromatinorganisationcausesmef2cgeneoverexpressioninintellectualdisabilityacasereport |
_version_ |
1724171473207164928 |
spelling |
doaj-af431e66ab844436af04e46b042eb9d42021-04-02T07:07:40ZengBMCBMC Medical Genomics1755-87942019-08-011211610.1186/s12920-019-0558-8Disruption of chromatin organisation causes MEF2C gene overexpression in intellectual disability: a case reportKevin Yauy0Anouck Schneider1Bee Ling Ng2Jean-Baptiste Gaillard3Satish Sati4Christine Coubes5Constance Wells6Magali Tournaire7Thomas Guignard8Pauline Bouret9David Geneviève10Jacques Puechberty11Franck Pellestor12Vincent Gatinois13Unité de Génétique Chromosomique, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Hôpital Arnaud de Villeneuve, CHU de MontpellierUnité de Génétique Chromosomique, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Hôpital Arnaud de Villeneuve, CHU de MontpellierCytometry Core Facility, The Wellcome Trust Sanger InstituteUnité de Génétique Chromosomique, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Hôpital Arnaud de Villeneuve, CHU de MontpellierChromatin and Cell Biology Group, CNRS-Institute of Human GeneticsService de Génétique Clinique, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Centre de Référence Anomalies du Développement et Syndromes Malformatifs, Hôpital Arnaud de Villeneuve, CHU de MontpellierService de Génétique Clinique, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Centre de Référence Anomalies du Développement et Syndromes Malformatifs, Hôpital Arnaud de Villeneuve, CHU de MontpellierUnité de Génétique Chromosomique, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Hôpital Arnaud de Villeneuve, CHU de MontpellierUnité de Génétique Chromosomique, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Hôpital Arnaud de Villeneuve, CHU de MontpellierUnité de Génétique Chromosomique, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Hôpital Arnaud de Villeneuve, CHU de MontpellierService de Génétique Clinique, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Centre de Référence Anomalies du Développement et Syndromes Malformatifs, Hôpital Arnaud de Villeneuve, CHU de MontpellierService de Génétique Clinique, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Centre de Référence Anomalies du Développement et Syndromes Malformatifs, Hôpital Arnaud de Villeneuve, CHU de MontpellierUnité de Génétique Chromosomique, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Hôpital Arnaud de Villeneuve, CHU de MontpellierUnité de Génétique Chromosomique, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Hôpital Arnaud de Villeneuve, CHU de MontpellierAbstract Background Balanced structural variants are mostly described in disease with gene disruption or subtle rearrangement at breakpoints. Case presentation Here we report a patient with mild intellectual deficiency who carries a de novo balanced translocation t(3;5). Breakpoints were fully explored by microarray, Array Painting and Sanger sequencing. No gene disruption was found but the chromosome 5 breakpoint was localized 228-kb upstream of the MEF2C gene. The predicted Topologically Associated Domains analysis shows that it contains only the MEF2C gene and a long non-coding RNA LINC01226. RNA studies looking for MEF2C gene expression revealed an overexpression of MEF2C in the lymphoblastoid cell line of the patient. Conclusions Pathogenicity of MEF2C overexpression is still unclear as only four patients with mild intellectual deficiency carrying 5q14.3 microduplications containing MEF2C are described in the literature. The microduplications in these individuals also contain other genes expressed in the brain. The patient presented the same phenotype as 5q14.3 microduplication patients. We report the first case of a balanced translocation leading to an overexpression of MEF2C similar to a functional duplication.http://link.springer.com/article/10.1186/s12920-019-0558-8Intellectual disability (ID)Topologically associated domains (TAD)MEF2C |